BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26002335)

  • 1. Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH).
    Aghazadeh Tabrizi M; Baraldi PG; Ruggiero E; Saponaro G; Baraldi S; Romagnoli R; Martinelli A; Tuccinardi T
    Eur J Med Chem; 2015 Jun; 97():289-305. PubMed ID: 26002335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
    Morera L; Labar G; Ortar G; Lambert DM
    Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A; Hanekamp W; Lehr M
    Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitors.
    Patel JZ; Parkkari T; Laitinen T; Kaczor AA; Saario SM; Savinainen JR; Navia-Paldanius D; Cipriano M; Leppänen J; Koshevoy IO; Poso A; Fowler CJ; Laitinen JT; Nevalainen T
    J Med Chem; 2013 Nov; 56(21):8484-96. PubMed ID: 24083878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
    Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A
    Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Isatin-Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
    Jaiswal S; Ayyannan SR
    ChemMedChem; 2022 Jan; 17(1):e202100559. PubMed ID: 34637598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones.
    Jaiswal S; Akhilesh ; Uniyal A; Tiwari V; Raja Ayyannan S
    Bioorg Med Chem; 2022 Apr; 60():116698. PubMed ID: 35296453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
    Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
    Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
    J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
    Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Acyl pyrazoles: Effective and tunable inhibitors of serine hydrolases.
    Otrubova K; Chatterjee S; Ghimire S; Cravatt BF; Boger DL
    Bioorg Med Chem; 2019 Apr; 27(8):1693-1703. PubMed ID: 30879861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation.
    Jaiswal S; Tripathi RKP; Ayyannan SR
    Biomed Pharmacother; 2018 Nov; 107():1611-1623. PubMed ID: 30257379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors.
    Granchi C; Rizzolio F; Bordoni V; Caligiuri I; Manera C; Macchia M; Minutolo F; Martinelli A; Giordano A; Tuccinardi T
    J Enzyme Inhib Med Chem; 2016; 31(1):137-46. PubMed ID: 25669350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loratadine analogues as MAGL inhibitors.
    Patel JZ; Ahenkorah S; Vaara M; Staszewski M; Adams Y; Laitinen T; Navia-Paldanius D; Parkkari T; Savinainen JR; Walczyński K; Laitinen JT; Nevalainen TJ
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1436-42. PubMed ID: 25752982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology.
    Lamani M; Malamas MS; Farah SI; Shukla VG; Almeida MF; Weerts CM; Anderson J; Wood JT; Farizatto KLG; Bahr BA; Makriyannis A
    Bioorg Med Chem; 2019 Dec; 27(23):115096. PubMed ID: 31629610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel propanamides as fatty acid amide hydrolase inhibitors.
    Deplano A; Morgillo CM; Demurtas M; Björklund E; Cipriano M; Svensson M; Hashemian S; Smaldone G; Pedone E; Luque FJ; Cabiddu MG; Novellino E; Fowler CJ; Catalanotti B; Onnis V
    Eur J Med Chem; 2017 Aug; 136():523-542. PubMed ID: 28535469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of carbamate derivatives as fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.
    Jaiswal S; Gupta G; Ayyannan SR
    Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200081. PubMed ID: 35924298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
    Jaiswal S; Ayyannan SR
    ChemMedChem; 2021 Jul; 16(14):2172-2187. PubMed ID: 33834617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a FLAP-consensus docking mixed strategy for the identification of new fatty acid amide hydrolase inhibitors.
    Poli G; Giuntini N; Martinelli A; Tuccinardi T
    J Chem Inf Model; 2015 Mar; 55(3):667-75. PubMed ID: 25746133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.